CAS RN: 1453315-99-5
tert-Butyl-8-hydroxy-5-oxa-2-azaspiro[3.4]octane-2-carboxylate 95%
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260629
100mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.05g, 0.1g, 0.25g, 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1453315-99-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.05g
≥95%
0
Out of Stock
Hong Kong
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1453315-99-5 / tert-butyl 8-hydroxy-5-oxa-2-azaspiro[3.4]octane-2-carboxylate
Standard CAS: 1453315-99-5
Multi CAS: No
Basic Information
copy
CAS
1453315-99-5 copy
Multi CAS
No copy
Molecular Formula
C11H19NO4 copy
Molecular Weight
229.270000 copy
Exact Mass
229.131408 copy
SMILES
CC(C)(C)OC(=O)N1CC2(C1)C(CCO2)O copy
InChI
InChI=1S/C11H19NO4/c1-10(2,3)16-9(14)12-6-11(7-12)8(13)4-5-15-11/h8,13H,4-7H2,1-3H3 copy
InChIKey
AUOIOKGLSQZUQZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Fraction Csp3
0.91 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
57.11 copy
TPSA
59 copy
LogP / Solubility
WLOGP
0.76 copy
MLOGP
0.67 copy
XLogP3
0.1 copy
Consensus LogP
0.51 copy
Log S (ESOL)
-1.74 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.99 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.78 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.58 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy
Safety & Transport
copy
Pictogram(s)
Acute Toxic copy
Signal
Danger copy
GHS Hazard Statements
H301 (97.4%): Toxic if swallowed [Danger Acute toxicity, oral] copy
Precautionary Statement Codes
P264, P270, P301+P316, P321, P330, P405, and P501 copy